Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Legend Biotech Corp (LEGN US)
Watchlist
81
Analysis
Health Care
•
China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Pharmaron Beijing
•
24 Feb 2023 08:55
Pharmaron Beijing Co Ltd (3759.HK/300759.CH) - Start to Enter a Vicious Circle
Due to slow layout in end-to-end integration/high uncertainty in CGT, Pharmaron has entered a vicious circle as CXO's fast-growing dividend period...
Xinyao (Criss) Wang
Follow
355 Views
Share
bullish
•
Genscript Biotech
•
17 Feb 2023 08:56
Genscript Biotech (1548.HK) - Inadequate Cognition Will Lead to Bad Investment Decisions
Genscript doesn’t equal to CGT CXO. Its core competitiveness is gene synthesis,which has larger potential than expected. However,there're concerns...
Xinyao (Criss) Wang
Follow
404 Views
Share
bearish
•
Shanghai Medicilon
•
12 Feb 2023 09:20
China Healthcare Weekly (Feb.10) - Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,
Medical insurance coverage of assisted reproduction has limited positive effects;Mr Market may not hold much hope for cell therapy after valuation...
Xinyao (Criss) Wang
Follow
427 Views
Share
bullish
•
Thematic (Sector/Industry)
•
11 Feb 2023 01:09
•
Syndicated
Opportunities and Challenges Hidden in the CGT Industry in China
GT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors...
EqualOcean
Follow
340 Views
Share
bullish
•
Thematic (Sector/Industry)
•
29 Jan 2023 09:17
China Healthcare Weekly (Jan.27) - Surgical Robots New Policy, COVID-19 Update, Policy Vacuum Period
New policy released to support development of surgical robot. COVID-19 is no longer an excuse for company's poor performance. It's a good time to...
Xinyao (Criss) Wang
Follow
329 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.10
x